Lantern Pharma

Performance

About Lantern Pharma

Lantern Pharma is an oncology-focused clinical stage biopharmaceutical company using artificial intelligence, genomics, and machine learning to accelerate cancer drug discovery and development. The company develops precision oncology therapies and its RADR platform aims to de-risk trials, identify responder populations, and facilitate companion diagnostics across multiple cancer indications. With a portfolio including lead drug candidates and an ADC program, Lantern emphasizes rapid, data-driven hypothesis testing in preclinical and clinical settings to shorten timelines and reduce costs. The organization portrays itself as leveraging AI-driven insights to improve FDA approval success in oncology, headquartered in the United States.